In Brief: Summit Technology/LCA-Vision
This article was originally published in The Gray Sheet
Executive Summary
Summit Technology/LCA-Vision: Summit agrees to divest its chain of photorefractive keratectomy (PRK) Vision Centers to LCA-Vision under an agreement announced July 23. Under the terms of the deal, LCA will issue about 17 mil. shares of its common stock for all of Refractive Centers International -- the Summit subsidiary which owns and operates the Vision Center business, including 19 centers across the U.S. The deal is valued at about $46.8 mil. based on LCA's July 22 closing price of 2-3/4. The transaction, still subject to standard regulatory conditions, also is awaiting "the closing of bank financing by LCA," Summit says. Summit announced its plan to either sell or spin off the business earlier this year due to its drain on company resources and its negative impact on customer relations with ophthalmic surgeons ("The Gray Sheet" Feb. 3, In Brief). Upon completion of the sale, LCA "will have over 40 vision correction centers in the U.S., Canada and Europe, making it one of the nation's largest providers of laser vision correction," Summit notes...
You may also be interested in...
Staar Surgical To Offer Ophthalmic Surgeons Stake In Laser-Center Chain
Staar Surgical will allow certain ophthalmic surgeons to purchase an equity stake in its chain of refractive laser eye surgery centers, the firm says.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”